Pharmacy Times

JANUARY 10, 2023

Approximately half of patients with heart failure do not require an implantable monitoring device or do not qualify for thoracic monitoring.

181

181

Pharma Phorum

JANUARY 13, 2023

The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.

Compounding 125

Compounding Pharmaceutical Companies Pharmaceutical Companies Communication 125

PharmExec

JANUARY 11, 2023

As new forms of cell and gene therapies continue to be developed, life sciences companies and payers need to find alternative ways to pay for these expensive treatments. Value-based contracts, though slow to gain traction so far, may provide the solution these groups are looking for.

110

110

PharmaVoice

JANUARY 12, 2023

Merck, Bristol Myers Squibb and others are taking small R&D steps in space that could lead to giant leaps for patients

105

105

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

Dosage

Pharmacy Times

JANUARY 12, 2023

Pharmacists report a myriad of reasons for joining the profession, including the connections they can build with patients.

158

158

Pharma Phorum

JANUARY 12, 2023

Bayer has signed an agreement with Google aimed at using high-level processing power to handle quantum chemistry calculations used to predict the chemical and physical properties of drug molecules at the atomic scale.

122

122

Fierce Healthcare

JANUARY 9, 2023

CVS, Cigna back kidney care coordination, tech startup Monogram Health's latest $375M raise. dmuoio. Mon, 01/09/2023 - 12:24

144

144

Pharmacy Times

JANUARY 11, 2023

Although cardiac amyloidosis was previously believed to be rare, more recent diagnostic advances and awareness have led to an increasing number of cases.

156

156

Pharma Phorum

JANUARY 11, 2023

Over the past few decades, data generation has veritably exploded. However, the ‘Big Data paradigm’ is not so much concerned with the volume of that data, but how businesses and, indeed, industries can derive meaningful insights from what has become a glut of information.

Compounding 122

Compounding 122

PharmaVoice

JANUARY 11, 2023

The chief strategy officer of Form Bio is harnessing the new company’s computing power and bioinformatics to spur a genomic revolution

98

98

PharmExec

JANUARY 11, 2023

What a changing economy and related trends could mean for 2023.

98

98

Pharmacy Times

JANUARY 9, 2023

The chronic and excessive use of opioids has been associated with a wide range of psychosocial effects on the patient.

156

156

Pharma Phorum

JANUARY 8, 2023

Before the main event at JP Morgan 2023 even kicks off, we’re checking out the Sachs Associates Neuroscience Innovation Forum on Sunday.

122

122

PharmaVoice

JANUARY 13, 2023

Execs at JPM sound off on moves companies can make to survive the challenging market conditions

98

98

PharmExec

JANUARY 9, 2023

"The customer is always right" — a commitment to omnichannel marketing is a commitment to serving the customer. David Laros of Beghou Consulting offers up this tersely written playbook on the topic.

98

98

Pharmacy Times

JANUARY 11, 2023

Psilocybin is derived from certain types of mushrooms and has been proven to affect serotonin receptors.

149

149

Pharma Phorum

JANUARY 10, 2023

Astellas has licensed rights to a drug developed by Selecta Biosciences that could make more patients eligible for treatment with its gene therapy for inherited neuromuscular disorder Pompe disease.

Immunization 119

Immunization FDA 119

PharmaVoice

JANUARY 9, 2023

How the IRLAB Therapeutics CEO is guiding the company in its development of potentially groundbreaking Parkinson’s disease treatments

98

98

PharmExec

JANUARY 11, 2023

As they are forced to do more with less, pharma commercial leaders should rethink their incentive programs to ensure their sales teams remain strong drivers of growth.

96

96

Pharmacy Times

JANUARY 13, 2023

Joseph Araujo, Chief Scientific Officer at Mindset Pharma, sat down to discuss natural vs. synthetic psychedelics.

144

144

Pharma Phorum

JANUARY 9, 2023

Novartis’ programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company.

119

119

Pharmafile

JANUARY 11, 2023

The FDA has cleared the ACL TightRope® II implant to treat torn knee ligaments in children and adolescents. The implant was developed with the aim of addressing a so-called ‘epidemic’ of knee injuries in young athletes who are at higher risk of anterior cruciate ligament (ACL) injuries. read more.

FDA 95

FDA Communication 95

Fierce Pharma

JANUARY 9, 2023

JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint. esagonowsky. Mon, 01/09/2023 - 09:55

134

134

Pharmacy Times

JANUARY 12, 2023

Frequent reassessments of therapy regimens address polypharmacy, particularly for older patients.

144

144

Pharma Phorum

JANUARY 9, 2023

We’re preparing to start JP Morgan week with a busy day Monday, with day 1 of the Informa Biotech Showcase, including a dedicated mini-event on Cell and Gene Therapy in the morning.

FDA 119

FDA 119

Fierce Healthcare

JANUARY 9, 2023

These socioeconomic factors may be indicators of long COVID risk, study says. fdiamond. Mon, 01/09/2023 - 16:48

133

133

Pharmaceutical Technology

JANUARY 13, 2023

Health Canada has granted approval to Enhertu (trastuzumab deruxtecan) to treat unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer.

Chemotherapy 128

Chemotherapy Adverse Reactions 128

Pharmacy Times

JANUARY 13, 2023

Jordan Sloshower, MD, MSc, explains his experience working in several clinical trials investigating psilocybin-assisted therapy.

139

139

Pharma Phorum

JANUARY 10, 2023

mRNA specialist BioNTech has driven its partnership with UK artificial intelligence InstaDeep into top gear, agreeing to buy the company outright in a cash and equity deal that values it at up to £562 million ($683 million).

Immunization 116

Immunization Vaccines 116

Fierce Healthcare

JANUARY 10, 2023

JPM23: CVS Health still weighing next steps as it plans foray into primary care. pminemyer. Tue, 01/10/2023 - 12:37

130

130

Fierce Pharma

JANUARY 10, 2023

JPM23: Pfizer entering the 'most important' 18-month stretch in company history, CEO says. esagonowsky. Tue, 01/10/2023 - 08:51

128

128

Pharmacy Times

JANUARY 12, 2023

Analysis shows 4-week daily dietary supplementation with the nuts increases the level of beneficial 12,13-DiHOME after physical activity.

139

139

Pharma Phorum

JANUARY 13, 2023

The ‘big three’ insulin producers Novo Nordisk, Eli Lilly, and Sanofi are being sued by the state of California for allegedly working together to set artificially inflated prices for their products.

105

105

Fierce Healthcare

JANUARY 10, 2023

LeanTaaS, Hospital IQ join forces to address hospital operational optimization. aburky. Tue, 01/10/2023 - 15:00

Hospitals 128

Hospitals 128

Fierce Pharma

JANUARY 9, 2023

JPM23: Moderna reaped $18.4B in COVID vaccine sales last year, projects at least $5B in 2023. kdunleavy. Mon, 01/09/2023 - 10:34

Vaccines 122

Vaccines 122

Pharmacy Times

JANUARY 11, 2023

With the release of the 2022 AHA/ACC Guidelines for the Management of Heart Failure, patients with HFpEF now have a wider range of treatment options.

139

139